MCVTMiller Convertible Growth ETF
Seeks to maximize total return comprising current income and capital appreciation while preserving capital.
Annual Cost
—
#5,913 of 5,913 · expensive
Fund Size
—
#5,913 of 5,913 · small
Return (1Y)Goal
+1.0%
Track Record
—
#5,913 of 5,913 · young
Performance
Total-return NAV · USDGrowth of $10,000
$9,817-1.8%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 35.0% of fund✓ well diversified
BRIDGEBIO PHARMA INC
3.9%
TRANSMEDICS GROUP INC
3.7%
MKS INC
3.7%
COHU INC
3.6%
CYBERARK SOFTWARE LTD
3.6%
UBER TECHNOLOGIES INC
3.5%
MACOM TECHNOLOGY SOLUTIONS HOLDINGS INC
3.3%
NOVA LTD
3.3%
LIGAND PHARMACEUTICALS INC
3.2%
AVNET INC
3.1%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
24.9%High
Year-on-year price swings
Max drawdown
-70.1%Severe
Worst peak-to-trough loss
Sharpe (3Y)
0.30Below average
Sortino (3Y)
0.46Moderate downside risk
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks to maximize total return comprising current income and capital appreciation while preserving capital.
- Strategy
- Actively manages a portfolio of convertible bonds to maximize total return, focusing on U.S. companies. The strategy includes minimizing volatility and preserving capital through various methods, such as investing in bonds with put provisions and short maturities.
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at MCVT. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-15